Peak Bio, Inc
Peak Bio, Inc., based in Pleasanton, CA, is a biopharmaceutical company focused on developing innovative therapies for inflammatory rare and specialty diseases, as well as cancer. With a management team boasting over 50 years of industry experience, the company is dedicated to addressing significant unmet medical needs through its research and development in antibody-drug conjugates and small molecule therapeutics.
One of their notable investigational therapies is PHP-303, a small molecule inhibitor of Neutrophil Elastase aimed at treating a rare genetic condition known as Alpha-1 Antitrypsin Deficiency (AATD). Additionally, Peak Bio is exploring novel toxins and antibody-drug conjugates (ADCs) that combine the precision of monoclonal antibodies with the potent effects of targeted small molecule therapies for oncology applications.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.